(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 26 000.00 |
Average Volume | 811 433 |
Market Cap | 1.03B |
EPS | HKD0 ( 2023-08-23 ) |
Next earnings date | ( HKD0 ) 2024-05-17 |
Last Dividend | HKD0.0300 ( 2023-05-23 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.81 |
ATR14 | HKD0 (0.00%) |
Zhongzhi Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zhongzhi Pharmaceutical Financials
Annual | 2023 |
Revenue: | HKD2.05B |
Gross Profit: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2023 |
Revenue: | HKD2.05B |
Gross Profit: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2022 |
Revenue: | HKD1.83B |
Gross Profit: | HKD1.07B (58.45 %) |
EPS: | HKD0.130 |
FY | 2021 |
Revenue: | HKD1.75B |
Gross Profit: | HKD1.06B (60.78 %) |
EPS: | HKD0.0630 |
Financial Reports:
No articles found.
Zhongzhi Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0300 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0350 | 2016-05-17 |
Last Dividend | HKD0.0300 | 2023-05-23 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | HKD0.282 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.68 | -- |
Div. Sustainability Score | 9.95 | |
Div.Growth Potential Score | 3.81 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8270.HK | No Dividend Player | 2023-06-30 | Sporadic | 0 | 0.00% | |
2020.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
1099.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
0168.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
3718.HK | Ex Dividend Junior | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
1668.HK | No Dividend Player | 2023-09-26 | Annually | 0 | 0.00% | |
0710.HK | Ex Dividend Junior | 2023-07-05 | Annually | 0 | 0.00% | |
2230.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
1243.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
0308.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0794 | 1.500 | 8.41 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0908 | 1.200 | 6.97 | 8.37 | [0 - 0.3] |
returnOnEquityTTM | 0.154 | 1.500 | 9.40 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.714 | -1.000 | 2.86 | -2.86 | [0 - 1] |
currentRatioTTM | 1.436 | 0.800 | 7.82 | 6.25 | [1 - 3] |
quickRatioTTM | 0.813 | 0.800 | 9.93 | 7.94 | [0.8 - 2.5] |
cashRatioTTM | 0.270 | 1.500 | 9.61 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.126 | -1.500 | 7.91 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0376 | -0.0753 | [0 - 20] |
debtEquityRatioTTM | 0.215 | -1.500 | 9.14 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.593 | 1.000 | 3.46 | 3.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0800 | 1.000 | -0.401 | -0.401 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.451 | 1.000 | 8.61 | 8.61 | [0.2 - 2] |
assetTurnoverTTM | 1.143 | 0.800 | 5.71 | 4.57 | [0.5 - 2] |
Total Score | 9.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.23 | 1.000 | 9.47 | 0 | [1 - 100] |
returnOnEquityTTM | 0.154 | 2.50 | 9.62 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0251 | -0.0753 | [0 - 30] |
dividendYielPercentageTTM | 7.98 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.714 | 1.500 | 2.86 | -2.86 | [0 - 1] |
pegRatioTTM | 0.0620 | 1.500 | -2.92 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0495 | 1.000 | -1.262 | 0 | [0.1 - 0.5] |
Total Score | 3.81 |
Zhongzhi Pharmaceutical
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators